Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Consider treatment response and tolerability when selecting the maintenance dosage Cardiovascular risk reduction maintenance dose: Either 2.4 mg (recommended) or 1.7 mg once weekly, based on patient response and tolerance
Contact your provider if you experience severe nausea that prevents adequate hydration or nutrition, signs of injection-site infection (increasing warmth, swelling, or discharge), or symptoms suggesting hypoglycemia (shakiness, sweating, severe dizziness) if you take diabetes medications
Frequently Asked Questions What is Retatrutide used for in research
Quick Answer: GLP-1 medications may contribute to reflux-like symptoms through delayed gastric emptying, though acid reflux is not consistently reported as a primary adverse effect in clinical trials
US$ 20.14
US$ 22.34
US$ 23.19
US$ 23.26
US$ 24.01
